BTK inhibitors for R/R MCL: current uses and insights from the ViPOR study VJHemOnc – Video Journal of Hematology & HemOnc 2:40 1 year ago 126 Скачать Далее
Selecting BTK inhibitors for patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 1 year ago 165 Скачать Далее
Pirtobrutinib for BTK inhibitor-naïve and BTK inhibitor pre-treated R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 471 Скачать Далее
Real-world outcomes of brexu-cel in patients with R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:45 1 year ago 70 Скачать Далее
Promising agents being explored in R/R MCL: bispecific antibodies and BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 2:03 11 months ago 151 Скачать Далее
Updated results of Phase I/II BRUIN study: pirtobrutinib in covalent BTK inhibitor pretreated MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:56 1 year ago 106 Скачать Далее
Updates from the BRUIN study – long-term safety of pirtobrutinib in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:01 1 year ago 200 Скачать Далее
Venetoclax: an unmet need in R/R mantle cell lymphoma after BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 3:27 5 years ago 211 Скачать Далее
BTK Inhibitor Use Proves Beneficial in Mantle Cell Lymphoma Treatment curetoday 1:26 4 years ago 184 Скачать Далее
How effective is CAR T-cell therapy for R/R MCL in a standard-of-care setting? Lymphoma Hub 11:26 1 year ago 210 Скачать Далее
Immunotherapeutic options for patients with MCL who progress on BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 3:11 1 year ago 44 Скачать Далее
Novel BTK Inhibitors: Overcoming Intolerance, Resistance, and Other Challenges in B-Cell Cancers PeerView Oncology 1:00:00 2 years ago 609 Скачать Далее
ViPOR regimen for R/R B-cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 2:30 5 years ago 434 Скачать Далее
BTK Inhibitors in MCL: Long-Term Safety & Efficacy Data Targeted Oncology 3:21 4 years ago 24 Скачать Далее
SYMPATICO: safety and efficacy of ibrutinib plus venetoclax for R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:18 3 years ago 87 Скачать Далее
BTK inhibitors and their place in the treatment landscape of B-cell malignancies VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 77 Скачать Далее
Comparing BTK Inhibitors in Patients With B-Cell Malignancies Targeted Oncology 1:01 3 years ago 246 Скачать Далее